Author Pöhlmann, Stefan
-
1999 | Journal Article
Co‐receptor Usage of BOB/GPR15 in Addition to CCR5 Has No Significant Effect on Replication of Simian Immunodeficiency Virus In Vivo
Pöhlmann, S.; Stolte, N.; Münch, J.; Ten Haaft, P.; Heeney, J.; Stahl‐Hennig, C. & Kirchhoff, F. (1999)
The Journal of Infectious Diseases, 180(5) pp. 1494-1502. DOI: https://doi.org/10.1086/315097
Details DOI
-
2007 | Journal Article
A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo
Pöhlmann, S.; Münch, J.; Aziz, S.; Reeves, J. D.; Otto, C.; Leslie, G. J. & Hofmann, H. et al. (2007)
Virology, 360(2) pp. 275-285. DOI: https://doi.org/10.1016/j.virol.2006.10.020
Details DOI
-
2011 | Journal Article
Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
Kühl, A.; Hoffmann, M.; Müller, M. A.; Munster, V. J.; Gnirß, K.; Kiene, M. & Tsegaye, T. S. et al. (2011)
The Journal of Infectious Diseases, 204(suppl_3) pp. S840-S849. DOI: https://doi.org/10.1093/infdis/jir306
Details DOI
-
2011 | Journal Article
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
Kühl, A.; Banning, C.; Marzi, A.; Votteler, J.; Steffen, I.; Bertram, S. & Glowacka, I. et al. (2011)
The Journal of Infectious Diseases, 204(Suppl. 3) pp. S850-S860. DOI: https://doi.org/10.1093/infdis/jir378
Details DOI
-
2011 | Journal Article
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Glowacka, I.; Bertram, S.; Müller, M. A.; Allen, P.; Soilleux, E.; Pfefferle, S. & Steffen, I. et al. (2011)
Journal of Virology, 85(9) pp. 4122-4134. DOI: https://doi.org/10.1128/JVI.02232-10
Details DOI
-
2011 | Journal Article
Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion
Simmons, G.; Bertram, S.; Glowacka, I.; Steffen, I.; Chaipan, C.; Agudelo, J. & Lu, K. et al. (2011)
Virology, 413(2) pp. 265-274. DOI: https://doi.org/10.1016/j.virol.2011.02.020
Details DOI
-
2011 | Journal Article
DC-SIGN: Access Portal for Sweet Viral Killers
Hofmann, H. & Pöhlmann, S. (2011)
Cell Host & Microbe, 10(1) pp. 5-7. DOI: https://doi.org/10.1016/j.chom.2011.07.003
Details DOI
-
2011 | Journal Article | Research Paper
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease
Bertram, S.; Glowacka, I.; Müller, M. A.; Lavender, H.; Gnirss, K.; Nehlmeier, I. & Niemeyer, D. et al. (2011)
Journal of Virology, 85(24) pp. 13363-13372. DOI: https://doi.org/10.1128/JVI.05300-11
Details DOI PMID PMC
-
2012 | Journal Article
Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
Gnirß, K.; Kühl, A.; Karsten, C.; Glowacka, I.; Bertram, S.; Kaup, F. & Hofmann, H. et al. (2012)
Virology, 424(1) pp. 3-10. DOI: https://doi.org/10.1016/j.virol.2011.11.031
Details DOI
-
2012 | Journal Article |
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
Bertram, S.; Heurich, A.; Lavender, H.; Gierer, S.; Danisch, S.; Perin, P. & Lucas, J. M. et al. (2012)
PLoS ONE, 7(4) art. e35876. DOI: https://doi.org/10.1371/journal.pone.0035876
Details DOI
-
2012 | Journal Article |
Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells
Winkler, M.; Bertram, S.; Gnirß, K.; Nehlmeier, I.; Gawanbacht, A.; Kirchhoff, F. & Ehrhardt, C. et al. (2012)
PLoS ONE, 7(8) art. e43337. DOI: https://doi.org/10.1371/journal.pone.0043337
Details DOI
-
2012 | Journal Article |
Host Cell Factors in Filovirus Entry: Novel Players, New Insights
Hofmann-Winkler, H.; Kaup, F. & Pöhlmann, S. (2012)
Viruses, 4(12) pp. 3336-3362. DOI: https://doi.org/10.3390/v4123336
Details DOI
-
2013 | Journal Article
Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Antibodies and Can Use DC-SIGN as a Receptor for pH-Dependent Entry into Human and Animal Cell Lines
Hofmann, H.; Li, X.; Zhang, X.; Liu, W.; Kühl, A.; Kaup, F. & Soldan, S. S. et al. (2013)
Journal of Virology, 87(8) pp. 4384-4394. DOI: https://doi.org/10.1128/JVI.02628-12
Details DOI
-
2013 | Journal Article
Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
Gierer, S.; Hofmann-Winkler, H.; Albuali, W. H.; Bertram, S.; Al-Rubaish, A. M.; Yousef, A. A. & Al-Nafaie, A. N. et al. (2013)
Emerging Infectious Diseases, 19(12) pp. 2034-2036. DOI: https://doi.org/10.3201/eid1912.130701
Details DOI
-
2013 | Journal Article
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
Simmons, G.; Zmora, P.; Gierer, S.; Heurich, A. & Pöhlmann, S. (2013)
Antiviral Research, 100(3) pp. 605-614. DOI: https://doi.org/10.1016/j.antiviral.2013.09.028
Details DOI
-
2013 | Journal Article
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Gierer, S.; Bertram, S.; Kaup, F.; Wrensch, F.; Heurich, A.; Krämer-Kühl, A. & Welsch, K. et al. (2013)
Journal of Virology, 87(10) pp. 5502-5511. DOI: https://doi.org/10.1128/JVI.00128-13
Details DOI
-
2013 | Journal Article
TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium
Bertram, S.; Dijkman, R.; Habjan, M.; Heurich, A.; Gierer, S.; Glowacka, I. & Welsch, K. et al. (2013)
Journal of Virology, 87(11) pp. 6150-6160. DOI: https://doi.org/10.1128/JVI.03372-12
Details DOI
-
2013 | Journal Article |
Platelet activation suppresses HIV-1 infection of T cells
Solomon Tsegaye, T.; Gnirß, K.; Rahe-Meyer, N.; Kiene, M.; Krämer-Kühl, A.; Behrens, G. & Münch, J. et al. (2013)
Retrovirology, 10(1) art. 48. DOI: https://doi.org/10.1186/1742-4690-10-48
Details DOI
-
2013 | Book Chapter
Cellular entry of retroviruses
Lindemann, D.; Steffen, I.& Pöhlmann, S. (2013)
In:Pöhlmann, Stefan; Simmons, Graham (Eds.), Viral Entry into Host Cells pp. 128-149. New York: Springer. DOI: https://doi.org/10.1007/978-1-4614-7651-1_7
Details DOI PMID PMC
-
2014 | Journal Article
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
Gehring, G.; Rohrmann, K.; Atenchong, N.; Mittler, E.; Becker, S.; Dahlmann, F. & Pöhlmann, S. et al. (2014)
Journal of Antimicrobial Chemotherapy, 69(8) pp. 2123-2131. DOI: https://doi.org/10.1093/jac/dku091
Details DOI
-
2014 | Journal Article
Bitter-sweet symphony: glycan–lectin interactions in virus biology
Van Breedam, W.; Pöhlmann, S.; Favoreel, H. W.; de Groot, R. J. & Nauwynck, H. J. (2014)
FEMS Microbiology Reviews, 38(4) pp. 598-632. DOI: https://doi.org/10.1111/1574-6976.12052
Details DOI
-
2014 | Journal Article
DESC1 and MSPL Activate Influenza A Viruses and Emerging Coronaviruses for Host Cell Entry
Zmora, P.; Blazejewska, P.; Moldenhauer, A.-S.; Welsch, K.; Nehlmeier, I.; Wu, Q. & Schneider, H. et al. (2014)
Journal of Virology, 88(20) pp. 12087-12097. DOI: https://doi.org/10.1128/JVI.01427-14
Details DOI
-
2014 | Journal Article |
IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
Wrensch, F.; Winkler, M. & Pöhlmann, S. (2014)
Viruses, 6(9) pp. 3683-3698. DOI: https://doi.org/10.3390/v6093683
Details DOI
-
2014 | Journal Article |
Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
Gnirß, K.; Fiedler, M.; Krämer-Kühl, A.; Bolduan, S.; Mittler, E.; Becker, S. & Schindler, M. et al. (2014)
Viruses, 6(4) pp. 1654-1671. DOI: https://doi.org/10.3390/v6041654
Details DOI
-
2014 | Journal Article |
Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells
Kiene, M.; Rethi, B.; Jansson, M.; Dillon, S.; Lee, E.; Lantto, R. & Wilson, C. et al. (2014)
PLoS ONE, 9(2) art. e88195. DOI: https://doi.org/10.1371/journal.pone.0088195
Details DOI PMID PMC
-
2014 | Journal Article | Research Paper
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein
Heurich, A.; Hofmann-Winkler, H.; Gierer, S.; Liepold, T.; Jahn, O. & Pöhlmann, S. (2014)
Journal of Virology, 88(2) pp. 1293-1307. DOI: https://doi.org/10.1128/JVI.02202-13
Details DOI PMID PMC
-
2015 | Journal Article
Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebolaviruses
Wrensch, F.; Karsten, C. B.; Gnirß, K.; Hoffmann, M.; Lu, K.; Takada, A. & Winkler, M. et al. (2015)
Journal of Infectious Diseases, 212(suppl 2) pp. S210-S218. DOI: https://doi.org/10.1093/infdis/jiv255
Details DOI
-
2015 | Journal Article
Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976
Hofmann-Winkler, H.; Gnirß, K.; Wrensch, F. & Pöhlmann, S. (2015)
Journal of Infectious Diseases, 212(Suppl. 2) pp. S172-S180. DOI: https://doi.org/10.1093/infdis/jiv101
Details DOI
-
2015 | Journal Article
Protease inhibitors targeting coronavirus and filovirus entry
Zhou, Y.; Vedantham, P.; Lu, K.; Agudelo, J.; Carrion, R.; Nunneley, J. W. & Barnard, D. et al. (2015)
Antiviral Research, 116 pp. 76-84. DOI: https://doi.org/10.1016/j.antiviral.2015.01.011
Details DOI
-
2015 | Journal Article |
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells.
Zmora, P.; Moldenhauer, A.-S.; Hofmann-Winkler, H. & Pöhlmann, S. (2015)
PloS one, 10(9) art. e0138380. DOI: https://doi.org/10.1371/journal.pone.0138380
Details DOI PMID PMC
-
2015 | Journal Article |
Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques.
Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Neumann, B.; Klippert, A. & Sauermann, U. et al. (2015)
Journal of virology, 89(22) pp. 11727-11733. DOI: https://doi.org/10.1128/JVI.01358-15
Details DOI PMID PMC
-
2016 | Journal Article
Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions
Guo, Y.; Sakonsinsiri, C.; Nehlmeier, I.; Fascione, M. A.; Zhang, H.; Wang, W. & Pöhlmann, S. et al. (2016)
Angewandte Chemie International Edition, 55(15) pp. 4738-4742. DOI: https://doi.org/10.1002/anie.201600593
Details DOI
-
2016 | Journal Article
The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases
Kühn, N.; Bergmann, S.; Kösterke, N.; Lambertz, R. L. O.; Keppner, A.; van den Brand, J. M. A. & Pöhlmann, S. et al. (2016)
Journal of Virology, 90(9) pp. 4298-4307. DOI: https://doi.org/10.1128/JVI.02693-15
Details DOI
-
2016 | Journal Article
The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies
Brinkmann, C.; Nehlmeier, I.; Walendy-Gnirß, K.; Nehls, J.; González Hernández, M.; Hoffmann, M. & Qiu, X. et al. (2016)
Journal of Virology, 90(24) pp. 11075-11086. DOI: https://doi.org/10.1128/JVI.01563-16
Details DOI
-
2016 | Journal Article |
The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release.
Spiegel, M.; Plegge, T. & Pöhlmann, S. (2016)
Viruses, 8(7). DOI: https://doi.org/10.3390/v8070202
Details DOI PMID PMC
-
2016 | Journal Article |
The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent.
Hoffmann, M.; González Hernández, M.; Berger, E.; Marzi, A. & Pöhlmann, S. (2016)
PloS one, 11(2) art. e0149651. DOI: https://doi.org/10.1371/journal.pone.0149651
Details DOI PMID PMC
-
2016 | Journal Article |
The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.
Hoffmann, M.; Krüger, N.; Zmora, P.; Wrensch, F.; Herrler, G. & Pöhlmann, S. (2016)
PloS one, 11(3) art. e0152134. DOI: https://doi.org/10.1371/journal.pone.0152134
Details DOI PMID PMC
-
2016 | Journal Article |
Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide
Plegge, T.; Hofmann-Winkler, H.; Spiegel, M. & Pöhlmann, S. (2016)
PLOS ONE, 11(11) art. e0166013. DOI: https://doi.org/10.1371/journal.pone.0166013
Details DOI PMID PMC
-
2017 | Journal Article
A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry
Hoffmann, M.; Crone, L.; Dietzel, E.; Paijo, J.; González-Hernández, M.; Nehlmeier, I. & Kalinke, U. et al. (2017)
Journal of Virology, 91(9) art. e00177-17. DOI: https://doi.org/10.1128/JVI.00177-17
Details DOI
-
2017 | Journal Article
Herpes B virus replication and viral lesions in the liver of a cynomolgus macaque which died from severe disease with rapid onset
Pöhlmann, S.; Suntz, M.; Akimkin, V.; Bleyer, M. & Kaul, A. (2017)
Journal of Medical Primatology, 46(5) pp. 256-259. DOI: https://doi.org/10.1111/jmp.12269
Details DOI
-
2017 | Journal Article
pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs
Gerlach, T.; Hensen, L.; Matrosovich, T.; Bergmann, J.; Winkler, M.; Peteranderl, C. & Klenk, H.-D. et al. (2017)
Journal of Virology, 91(11) art. e00246-17. DOI: https://doi.org/10.1128/JVI.00246-17
Details DOI
-
2017 | Journal Article
Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins
Wrensch, F.; Hoffmann, M.; Gärtner, S.; Nehlmeier, I.; Winkler, M. & Pöhlmann, S. (2017)
Journal of Virology, 91(2) art. e01488-16. DOI: https://doi.org/10.1128/JVI.01488-16
Details DOI
-
2017 | Journal Article |
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.
Reinke, L. M.; Spiegel, M.; Plegge, T.; Hartleib, A.; Nehlmeier, I.; Gierer, S. & Hoffmann, M. et al. (2017)
PloS one, 12(6) art. e0179177. DOI: https://doi.org/10.1371/journal.pone.0179177
Details DOI PMID PMC
-
2017 | Journal Article |
Dissecting Multivalent Lectin–Carbohydrate Recognition Using Polyvalent Multifunctional Glycan-Quantum Dots
Guo, Y.; Nehlmeier, I.; Poole, E.; Sakonsinsiri, C.; Hondow, N.; Brown, A. & Li, Q. et al. (2017)
Journal of the American Chemical Society, 139(34) pp. 11833-11844. DOI: https://doi.org/10.1021/jacs.7b05104
Details DOI PMID PMC
-
2017 | Journal Article |
Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin
Zmora, P.; Molau-Blazejewska, P.; Bertram, S.; Walendy-Gnirß, K.; Nehlmeier, I.; Hartleib, A. & Moldenhauer, A.-S. et al. (2017)
PLOS ONE, 12(5) art. e0176597. DOI: https://doi.org/10.1371/journal.pone.0176597
Details DOI PMID PMC
-
2017 | Journal Article |
Rhesus macaque IFITM3 gene polymorphisms and SIV infection
Winkler, M.; Gärtner, S.; Wrensch, F.; Krawczak, M.; Sauermann, U. & Pöhlmann, S. (2017)
PLOS ONE, 12(3) art. e0172847. DOI: https://doi.org/10.1371/journal.pone.0172847
Details DOI PMID PMC
-
2018 | Journal Article
A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism
González-Hernández, M.; Hoffmann, M.; Brinkmann, C.; Nehls, J.; Winkler, M.; Schindler, M. & Pöhlmann, S. (2018)
Journal of Virology, 92(13) art. e00403-18. DOI: https://doi.org/10.1128/JVI.00403-18
Details DOI
-
2018 | Journal Article
Cell Entry of Influenza A Viruses: Sweet Talk between HA and CaV1.2
Hoffmann, M. & Pöhlmann, S. (2018)
Cell Host & Microbe, 23(6) pp. 697-699. DOI: https://doi.org/10.1016/j.chom.2018.05.019
Details DOI
-
2019 | Journal Article
Seroprevalence of viral infections in captive rhesus and cynomolgus macaques
Kaul, A.; Schönmann, U. & Pöhlmann, S. (2019)
Primate Biology, 6(1) pp. 1-6. DOI: https://doi.org/10.5194/pb-6-1-2019
Details DOI
-
2019 | Journal Article |
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins
Braun, E.; Hotter, D.; Koepke, L.; Zech, F.; Groß, R.; Sparrer, K. M. & Müller, J. A. et al. (2019)
Cell Reports, 27(7) art. 2104.e10. DOI: https://doi.org/10.1016/j.celrep.2019.04.063
Details DOI PMID PMC
-
2019 | Journal Article |
Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins
Plegge, T.; Spiegel, M.; Krüger, N.; Nehlmeier, I.; Winkler, M.; González Hernández, M. & Pöhlmann, S. (2019)
PLOS ONE, 14(4) art. e0214968. DOI: https://doi.org/10.1371/journal.pone.0214968
Details DOI PMID PMC
-
2019 | Journal Article |
A system for production of defective interfering particles in the absence of infectious influenza A virus
Bdeir, N.; Arora, P.; Gärtner, S.; Hoffmann, M.; Reichl, U.; Pöhlmann, S. & Winkler, M. (2019)
PlOS ONE, 14(3) art. e0212757. DOI: https://doi.org/10.1371/journal.pone.0212757
Details DOI PMID PMC
-
2020 | Journal Article |
Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation
Hofmann-Winkler, H.; Moerer, O.; Alt-Epping, S.; Bräuer, A.; Büttner, B.; Müller, M. & Fricke, T. et al. (2020)
Critical Care Explorations, 2(11) art. e0284. DOI: https://doi.org/10.1097/CCE.0000000000000284
Details DOI
-
2021 | Journal Article
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Hoffmann, M.; Hofmann-Winkler, H.; Krüger, N.; Kempf, A.; Nehlmeier, I.; Graichen, L. & Arora, P. et al. (2021)
Cell Reports, 36(3) art. S2211124721008287. DOI: https://doi.org/10.1016/j.celrep.2021.109415
Details DOI
-
2021 | Journal Article
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
Behrens, G. M.; Cossmann, A.; Stankov, M. V; Nehlmeier, I.; Kempf, A.; Hoffmann, M. & Pöhlmann, S. (2021)
The Lancet, 398(10305) pp. 1041-1042. DOI: https://doi.org/10.1016/S0140-6736(21)01891-2
Details DOI
-
2021 | Journal Article
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Hoffmann, M.; Zhang, L.; Krüger, N.; Graichen, L.; Kleine-Weber, H.; Hofmann-Winkler, H. & Kempf, A. et al. (2021)
Cell Reports, 35(3) pp. 109017. DOI: https://doi.org/10.1016/j.celrep.2021.109017
Details DOI
-
2021 | Journal Article
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Hoffmann, M.; Arora, P.; Groß, R.; Seidel, A.; Hörnich, B. F.; Hahn, A. S. & Krüger, N. et al. (2021)
Cell, 184(9) pp. 2384-2393.e12. DOI: https://doi.org/10.1016/j.cell.2021.03.036
Details DOI
-
2021 | Journal Article
The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection
Imre, G.; Krähling, V.; Eichler, M.; Trautmann, S.; Ferreirós, N.; Aman, M. J. & Kashanchi, F. et al. (2021)
iScience, 24(4) pp. 102266. DOI: https://doi.org/10.1016/j.isci.2021.102266
Details DOI
-
2021 | Journal Article
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Hoffmann, M.; Hofmann-Winkler, H.; Smith, J. C.; Krüger, N.; Arora, P.; Sørensen, L. K. & Søgaard, O. S. et al. (2021)
EBioMedicine, 65 art. 103255. DOI: https://doi.org/10.1016/j.ebiom.2021.103255
Details DOI
-
2021 | Journal Article |
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection
Krüger, N.; Rocha, C.; Runft, S.; Krüger, J.; Färber, I.; Armando, F. & Leitzen, E. et al. (2021)
International Journal of Molecular Sciences, 22(19) pp. 10636. DOI: https://doi.org/10.3390/ijms221910636
Details DOI
-
2021 | Journal Article |
Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
Hoffmann, M. & Pöhlmann, S. (2021)
Cell Research, 32(1) pp. 1-2. DOI: https://doi.org/10.1038/s41422-021-00603-9
Details DOI
-
2021 | Journal Article |
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
Hein, M. D.; Arora, P.; Marichal-Gallardo, P.; Winkler, M.; Genzel, Y.; Pöhlmann, S. & Schughart, K. et al. (2021)
BMC Biology, 19(1) art. 91. DOI: https://doi.org/10.1186/s12915-021-01020-5
Details DOI
-
2021 | Journal Article |
Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity
Bdeir, N.; Arora, P.; Gärtner, S.; Pöhlmann, S. & Winkler, M. (2021)
Scientific Reports, 11(1) art. 20477. DOI: https://doi.org/10.1038/s41598-021-99691-1
Details DOI
-
2021 | Journal Article |
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
Abusukhun, M.; Winkler, M. S.; Pöhlmann, S.; Moerer, O.; Meissner, K.; Tampe, B. & Hofmann-Winkler, H. et al. (2021)
Frontiers in Immunology, 12. DOI: https://doi.org/10.3389/fimmu.2021.784989
Details DOI
-
2021 | Journal Article
Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
Becker, K. A.; Carpinteiro, A.; Hoffmann, M.; Pöhlmann, S.; Kornhuber, J. & Gulbins, E. (2021)
STAR Protocols, 2(1) pp. 100356. DOI: https://doi.org/10.1016/j.xpro.2021.100356
Details DOI
-
2021 | Journal Article
Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection
Winkler, M.; Claus, R.; Schilder, M.; Pöhlmann, S.; Coldewey, S.; Grundmann, J. & Fricke, T. et al. (2021)
Clinical Science, 135(24) pp. 2781-2791. DOI: https://doi.org/10.1042/CS20210666
Details DOI
-
2021 | Journal Article |
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study
Tampe, D.; Hakroush, S.; Bösherz, M.-S.; Franz, J.; Hofmann-Winkler, H.; Pöhlmann, S. & Kluge, S. et al. (2021)
Frontiers in Medicine, 8. DOI: https://doi.org/10.3389/fmed.2021.644715
Details DOI PMID PMC
-
2021 | Journal Article |
Dalbavancin: novel candidate for COVID-19 treatment
Hoffmann, M.; Jin, Y. & Pöhlmann, S. (2021)
Cell Research, 31(3) pp. 243-244. DOI: https://doi.org/10.1038/s41422-020-00459-5
Details DOI
-
2021 | Journal Article |
Mutation D614G increases SARS-CoV-2 transmission
Arora, P.; Pöhlmann, S. & Hoffmann, M. (2021)
Signal Transduction and Targeted Therapy, 6(1). DOI: https://doi.org/10.1038/s41392-021-00502-w
Details DOI
-
2021 | Journal Article |
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Wettstein, L.; Weil, T.; Conzelmann, C.; Müller, J. A.; Groß, R.; Hirschenberger, M. & Seidel, A. et al. (2021)
Nature Communications, 12(1). DOI: https://doi.org/10.1038/s41467-021-21972-0
Details DOI
-
2021 | Journal Article |
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
Hammerschmidt, S. I.; Bosnjak, B.; Bernhardt, G.; Friedrichsen, M.; Ravens, I.; Dopfer-Jablonka, A. & Hoffmann, M. et al. (2021)
Cellular & Molecular Immunology, 18(10) pp. 2455-2456. DOI: https://doi.org/10.1038/s41423-021-00755-z
Details DOI
-
2021 | Journal Article |
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Sidarovich, A.; Winkler, M. S. & Schulz, S. et al. (2021)
Cellular & Molecular Immunology, 18(11) pp. 2557-2559. DOI: https://doi.org/10.1038/s41423-021-00772-y
Details DOI
-
2021 | Journal Article |
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
Arora, P.; Rocha, C.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S. & Lier, M. et al. (2021)
Cellular & Molecular Immunology, 18(12) pp. 2673-2675. DOI: https://doi.org/10.1038/s41423-021-00779-5
Details DOI
-
2021 | Journal Article |
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Lapuente, D.; Fuchs, J.; Willar, J.; Vieira Antão, A.; Eberlein, V.; Uhlig, N. & Issmail, L. et al. (2021)
Nature Communications, 12(1) art. 6871. DOI: https://doi.org/10.1038/s41467-021-27063-4
Details DOI
-
2022 | Journal Article
Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein
Arora, P.; Sidarovich, A.; Graichen, L.; Hörnich, B.; Hahn, A.; Hoffmann, M. & Pöhlmann, S. (2022)
PLoS One, 17(3) art. e0265453. DOI: https://doi.org/10.1371/journal.pone.0265453
Details DOI
-
2022 | Journal Article
Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Cossmann, A.; Stankov, M. V & Jäck, H.-M. et al. (2022)
The Lancet Infectious Diseases, 22(8) pp. 1117-1118. DOI: https://doi.org/10.1016/S1473-3099(22)00422-4
Details DOI
-
2022 | Journal Article
Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
Hoffmann, M.; Arora, P. & Pöhlmann, S. (2022)
Clinical and Translational Medicine, 12(5). DOI: https://doi.org/10.1002/ctm2.839
Details DOI
-
2022 | Journal Article
Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Jäck, H.-M.; Pöhlmann, S. & Hoffmann, M. (2022)
The Lancet Infectious Diseases,. DOI: https://doi.org/10.1016/S1473-3099(22)00733-2
Details DOI
-
2022 | Journal Article
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Hoffmann, M.; Krüger, N.; Schulz, S.; Cossmann, A.; Rocha, C.; Kempf, A. & Nehlmeier, I. et al. (2022)
Cell, 185(3) pp. 447-456.e11. DOI: https://doi.org/10.1016/j.cell.2021.12.032
Details DOI
-
2022 | Journal Article
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
Groß, R.; Zanoni, M.; Seidel, A.; Conzelmann, C.; Gilg, A.; Krnavek, D. & Erdemci-Evin, S. et al. (2022)
eBioMedicine, 75 art. S2352396421005557. DOI: https://doi.org/10.1016/j.ebiom.2021.103761
Details DOI
-
2022 | Journal Article |
Primate Simplexviruses Differ in Tropism for Macaque Cells
Hofmann-Winkler, H.; Siregar, A. R.; Esiyok, N.; Rodríguez-Polo, I.; Gärtner, S.; Behr, R. & Pöhlmann, S. et al. (2022)
Microorganisms, 11(1) pp. 26. DOI: https://doi.org/10.3390/microorganisms11010026
Details DOI
-
2022 | Journal Article |
A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2
Rahman Siregar, A.; Gärtner, S.; Götting, J.; Stegen, P.; Kaul, A.; Schulz, T. F. & Pöhlmann, S. et al. (2022)
Viruses, 14(1) pp. 91. DOI: https://doi.org/10.3390/v14010091
Details DOI
-
2022 | Journal Article |
Omicron: Master of immune evasion maintains robust ACE2 binding
Hoffmann, M.; Zhang, L. & Pöhlmann, S. (2022)
Signal Transduction and Targeted Therapy, 7(1) art. 118. DOI: https://doi.org/10.1038/s41392-022-00965-5
Details DOI
-
2022 | Journal Article |
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S.; Lier, M. & Schulz, S. et al. (2022)
Cellular & Molecular Immunology,. DOI: https://doi.org/10.1038/s41423-021-00811-8
Details DOI
-
2022 | Journal Article | Research Paper |
Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract
Färber, I.; Krüger, J.; Rocha, C.; Armando, F.; von Köckritz-Blickwede, M.; Pöhlmann, S. & Braun, A. et al. (2022)
Viruses, 14(4) pp. 828. DOI: https://doi.org/10.3390/v14040828
Details DOI
-
2022 | Journal Article
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
Heinen, N.; Marheinecke, C. S.; Bessen, C.; Blazquez-Navarro, A.; Roch, T.; Stervbo, U. & Anft, M. et al. (2022)
Frontiers in Immunology, 13 art. 1062210. DOI: https://doi.org/10.3389/fimmu.2022.1062210
Details DOI PMID PMC
-
2022 | Journal Article
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Wagoner, J.; Herring, S.; Hsiang, T.-Y.; Ianevski, A.; Biering, S. B.; Xu, S. & Hoffmann, M. et al. (2022)
Microbiology Spectrum, 10(5) art. e03331-22. DOI: https://doi.org/10.1128/spectrum.03331-22
Details DOI PMID PMC
-
2022 | Journal Article
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
Schlör, A.; Hirschberg, S.; Amor, G. B.; Meister, T. L.; Arora, P.; Pöhlmann, S. & Hoffmann, M. et al. (2022)
Frontiers in Immunology, 13 art. 930975. DOI: https://doi.org/10.3389/fimmu.2022.930975
Details DOI PMID PMC
-
2022 | Journal Article |
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Jacobsen, H.; Strengert, M.; Maaß, H.; Ynga Durand, M. A.; Katzmarzyk, M.; Kessel, B. & Harries, M. et al. (2022)
Scientific Reports, 12(1) art. 19858. DOI: https://doi.org/10.1038/s41598-022-22552-y
Details DOI PMID PMC
-
2022 | Journal Article | Research Paper |
Mutagenic Analysis of the HIV Restriction Factor Shiftless
Jäger, N.; Ayyub, S. A.; Korniy, N.; Peske, F.; Hoffmann, M.; Rodnina, M. V. & Pöhlmann, S. (2022)
Viruses, 14(7). DOI: https://doi.org/10.3390/v14071454
Details DOI
-
2022 | Journal Article |
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
Sidarovich, A.; Krüger, N.; Rocha, C.; Graichen, L.; Kempf, A.; Nehlmeier, I. & Lier, M. et al. (2022)
Viruses, 14(11) art. 2475. DOI: https://doi.org/10.3390/v14112475
Details DOI PMID PMC
-
2022 | Journal Article |
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
Arora, P.; Zhang, L.; Rocha, C.; Graichen, L.; Nehlmeier, I.; Kempf, A. & Cossmann, A. et al. (2022)
International Journal of Molecular Sciences, 23(22) pp. 14057. DOI: https://doi.org/10.3390/ijms232214057
Details DOI
-
2023 | Journal Article
Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
Budhadev, D.; Hooper, J.; Rocha, C.; Nehlmeier, I.; Kempf, A. M.; Hoffmann, M. & Krüger, N. et al. (2023)
JACS Au, 3(6) pp. 1755-1766. DOI: https://doi.org/10.1021/jacsau.3c00163
Details DOI
-
2023 | Journal Article
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
Hoffmann, M.; Behrens, G. M N; Arora, P.; Kempf, A.; Nehlmeier, I.; Cossmann, A. & Manthey, L. et al. (2023)
The Lancet Infectious Diseases, 23(1) pp. 25-28. DOI: https://doi.org/10.1016/S1473-3099(22)00792-7
Details DOI
-
2023 | Journal Article
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
Arora, P.; Cossmann, A.; Schulz, S. R; Ramos, G. M.; Stankov, M. V; Jäck, H.-M. & Behrens, G. M N et al. (2023)
The Lancet Infectious Diseases, 23(2) pp. 147-148. DOI: https://doi.org/10.1016/S1473-3099(22)00831-3
Details DOI
-
2023 | Journal Article
Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses
Reiter, S.; Gärtner, S.; Decker, K.; Pöhlmann, S. & Winkler, M. (2023)
PLoS One, 18(5) art. e0284048. DOI: https://doi.org/10.1371/journal.pone.0284048
Details DOI
-
2023 | Journal Article |
Omicron subvariant BA.5 efficiently infects lung cells
Hoffmann, M.; Wong, L. Wong, Lok-Yin Roy; Arora, P.; Zhang, L.; Rocha, C.; Odle, A. & Nehlmeier, I. et al. (2023)
Nature Communications, 14(1). DOI: https://doi.org/10.1038/s41467-023-39147-4
Details DOI
-
2023 | Journal Article
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
Zhang, L.; Kempf, A.; Nehlmeier, I.; Cossmann, A.; Dopfer-Jablonka, A.; Stankov, M. V & Schulz, S. R et al. (2023)
The Lancet Infectious Diseases, 23(10) pp. e391-e392. DOI: https://doi.org/10.1016/S1473-3099(23)00547-9
Details DOI
-
2023 | Journal Article
Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
Katzmarzyk, M.; Clesle, D. C.; van den Heuvel, J.; Hoffmann, M.; Garritsen, H.; Pöhlmann, S. & Jacobsen, H. et al. (2023)
Frontiers in Immunology, 14 art. 1288794. DOI: https://doi.org/10.3389/fimmu.2023.1288794
Details DOI